drugset / Trial / NCT02933814
Liposomal Bupivacaine in Ambulatory Hand Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is being done to evaluate pain management regimens following ambulatory hand surgery. Improved pain control may be associated with decreased complications, decreased pain scores, decreased opioid dependence, improved patient comfort and satisfaction, and reduced healthcare costs. Liposomal bupivacaine is an FDA-approved local anesthetic. There will be two groups. One group will receive liposomal bupivacaine. One group will not. The results will be compared. Patients will be over the age of 18 ambulatory hand surgery. Approximately 40 subjects will participate in this study at LLU.
Timeline
- Start
- 2018-02-09
- Primary completion
- 2019-02
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 12.5 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 25 mg | Other |
Indications
No indication recorded.